Salarius Pharmaceuticals Inc (SLRX) support and resistance · $4.9M cap
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
This page maps Salarius Pharmaceuticals Inc (SLRX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
SLRX currently screens at market cap $4.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new SLRX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the SLRX quote page for the session range and the stock page for the full model.
Not investment advice.